| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/23/1999 | WO1999047929A1 Development of human monoclonal antibodies and uses thereof |
| 09/23/1999 | WO1999047927A1 An equine neospora isolate and its uses |
| 09/23/1999 | WO1999047925A2 Methods and compositions for diagnosis of rheumatoid arthritis |
| 09/23/1999 | WO1999047683A1 Gene encoding labyrinthin, a marker for cancer |
| 09/23/1999 | WO1999047677A2 Polypeptides homologous to vegf and bmp1 |
| 09/23/1999 | WO1999047675A1 Mu-1, member of the cytokine receptor family |
| 09/23/1999 | WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | WO1999047673A2 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | WO1999047670A1 Mammalian sodium channel proteins |
| 09/23/1999 | WO1999047669A2 Human nucleic acid sequences from tissue of breast tumors |
| 09/23/1999 | WO1999047662A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047658A1 The cytokine family member ef-7 |
| 09/23/1999 | WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 09/23/1999 | WO1999047639A2 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | WO1999047564A1 Fas-associated polypeptides |
| 09/23/1999 | WO1999047562A1 Nephrin gene and protein |
| 09/23/1999 | WO1999047561A1 Ribonucleotide polypeptides containing metal |
| 09/23/1999 | WO1999047554A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 09/23/1999 | WO1999047544A1 nrdF |
| 09/23/1999 | WO1999047540A1 95 human secreted proteins |
| 09/23/1999 | WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 09/23/1999 | WO1999047535A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 09/23/1999 | WO1999047170A1 Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists |
| 09/23/1999 | WO1999047169A1 Methods to provoke anti-cancer immune responses |
| 09/23/1999 | WO1999047166A1 IMMUNOMODULATORY FRAGMENTS OF POLYCLONAL ANTILYMPHOCYTE GLOBULINS (ALGs) AND USES THEREOF |
| 09/23/1999 | WO1999047162A1 Products in the treatment of cancer |
| 09/23/1999 | WO1999047147A1 nrdG |
| 09/23/1999 | WO1999041374A3 Human short-chain tnf-receptor family protein |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | WO1999027944A9 Prevention and treatment of amyloidogenic disease |
| 09/23/1999 | DE19841413C1 New potassium channel protein, Kv6.2, used to screen for specific modulators, potentially useful e.g. as antiarrhythmic agents |
| 09/23/1999 | DE19813839A1 Human nucleic acid sequences and protein products from tumor breast tissue, useful for breast cancer therapy |
| 09/23/1999 | DE19813835A1 Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy |
| 09/23/1999 | DE19802139C1 Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung A monoclonal antibody specific for activated coagulation factor VII and its use |
| 09/23/1999 | CA2625284A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/23/1999 | CA2324337A1 Products in the treatment of cancer |
| 09/23/1999 | CA2323830A1 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 09/23/1999 | CA2323761A1 95 human secreted proteins |
| 09/23/1999 | CA2323724A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | CA2323637A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | CA2323494A1 Gene encoding labyrinthin, a marker for cancer |
| 09/23/1999 | CA2323238A1 Methods and compositions for diagnosis of rheumatoid arthritis |
| 09/23/1999 | CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | CA2323083A1 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | CA2322795A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2321113A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | CA2321091A1 An equine neospora isolate and its uses |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943688A2 Polypeptide of N-acetylglucosamine-6-0-sulfotransferase and DNA encoding the same |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943683A1 Human vanilloid receptor homologue Vanilrep1 |
| 09/22/1999 | EP0943625A1 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method of the hybridomas and antigen proteins recognized by the antibodies |
| 09/22/1999 | EP0942998A1 Notch |
| 09/22/1999 | EP0942992A1 O-fucosyltransferase |
| 09/22/1999 | EP0942991A2 Identification of inhibitors that prevent access of telomerase to chromosomal terminus |
| 09/22/1999 | EP0942987A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 09/22/1999 | EP0942985A1 Broad-spectrum delta-endotoxins |
| 09/22/1999 | EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/22/1999 | EP0942983A2 $i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES |
| 09/22/1999 | EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/22/1999 | EP0942981A1 Fibroblast growth factor-13 |
| 09/22/1999 | EP0942980A1 Tumor-associated kazal inhibitor with pec-60 homology |
| 09/22/1999 | EP0942978A2 Methods for producing the anaphase promoting complex |
| 09/22/1999 | EP0942977A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 09/22/1999 | EP0942976A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 09/22/1999 | EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 09/22/1999 | EP0942968A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL V H? AND V$g(k) REGIONS AND ANTIBODIES PRODUCED THEREFROM |
| 09/22/1999 | EP0942964A2 Thermostable polymerases having altered fidelity |
| 09/22/1999 | EP0942961A1 Process for producing tumoricide t-lymphocytes |
| 09/22/1999 | EP0942959A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 09/22/1999 | EP0942934A2 Receptor tyrosine kinase genes |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942929A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
| 09/22/1999 | EP0942928A1 Subunit respiratory syncytial virus vaccine preparation |
| 09/22/1999 | EP0942756A2 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation) |
| 09/22/1999 | EP0942750A1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | EP0540525B1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 09/22/1999 | CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/22/1999 | CN1228962A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/21/1999 | US5955647 Method for using tobacco mosaic virus to overproduce peptides and proteins |
| 09/21/1999 | US5955594 Nucleic acids encoding proteins for early liver development |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955584 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 09/21/1999 | US5955583 Antibodies which bind to cyclic guanosine 3', 5' monophosphate enzyme involved in signal transduction |
| 09/21/1999 | US5955582 For immunoassay diagnosis and monitoring of conditions like diabetes |
| 09/21/1999 | US5955580 Vaccines for nontypable haemophilus influenzae |
| 09/21/1999 | US5955572 Structural mimics of RGD-binding sites |
| 09/21/1999 | US5955444 Method of inhibiting abnormal tau hyper phosphorylation in a cell |
| 09/21/1999 | US5955441 Genetic inhibition of complement mediated inflammatory response |
| 09/21/1999 | US5955429 Human apoptosis-associated protein |
| 09/21/1999 | US5955428 DNA encoding human metallothionein |
| 09/21/1999 | US5955422 Production of erthropoietin |
| 09/21/1999 | US5955366 Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins |
| 09/21/1999 | US5955364 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 09/21/1999 | US5955358 Adjusting nucleic acids to increase binding of encoded antibody by randomly incorporating complementarity determining regions; enhancing immune response |
| 09/21/1999 | US5955356 Nucleic acids, vectors, and host cells including mycobacterium derived sequences |